Detalhe da pesquisa
1.
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
J Intern Med
; 294(6): 761-774, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592715
2.
Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study.
BJOG
; 130(3): 303-311, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156839
3.
Hereditary hemorrhagic telangiectasia and health-related quality of life: a qualitative investigation.
Qual Life Res
; 29(5): 1291-1299, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907872
4.
Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial.
JAMA
; 316(9): 934-42, 2016 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27599328
5.
Ultra-low dose chest CT for the diagnosis of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
Diagn Interv Imaging
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604894
6.
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
Eur J Med Genet
; 65(10): 104575, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940549
7.
Classifying Ectopia Lentis in Marfan Syndrome into Five Grades of Increasing Severity.
J Clin Med
; 9(3)2020 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32155956
8.
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
J Clin Med
; 9(5)2020 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357559
9.
Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
Sci Rep
; 9(1): 11986, 2019 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427745
10.
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients.
PLoS One
; 12(11): e0188943, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190827
11.
Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia.
MAbs
; 7(3): 630-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25751241
12.
ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
MAbs
; 6(3): 794-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481211